Literature DB >> 17043162

Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats.

Gerard D'Angelo1, James D Mintz, John E Tidwell, Ann M Schreihofer, David M Pollock, David W Stepp.   

Abstract

Clinical studies have demonstrated that the pressor response to acute stress is larger in obese versus lean individuals. We therefore tested the hypotheses that the pressor response to behavioral stress is greater in obese (OZRs) versus lean Zucker rats (LZRs) and that reduced beta-adrenergic-mediated vasodilation contributes to the enhanced pressor response. Animals were restrained and subjected to acute pulsatile air jet stress (3 minutes), followed by a poststress period of 20 minutes; beta-adrenergic blockade was achieved with propranolol (5 mg/kg, IV) given 15 minutes before the start of air jet stress. Mean arterial pressure (MAP) was continuously monitored by telemetry. Untreated OZRs responded with a greater integrated pressor response (area under the curve [AUC]) to acute stress (41.2+/-6.1 versus 21.2+/-3.3 mm Hgx3 minutes, OZR versus LZR; P<0.05) and significantly reduced poststress recovery of MAP. Beta-adrenergic blockade had no effect on stress AUC in either LZRs or OZRs but significantly attenuated the poststress recovery of MAP in LZRs only (poststress AUC: -100.1+/-48.1 versus 49.0+/-13.5 mm Hgx20 minutes, untreated versus propranolol; P<0.05). In anesthetized animals, significantly smaller increases in mesenteric vascular conductance contributed to blunted depressor responses to isoproterenol in OZRs versus LZRs, suggesting that beta-adrenergic stimulation causes a greater reduction in total peripheral resistance in lean versus obese animals. We conclude that beta-adrenergic-mediated vasodilation facilitates blood pressure recovery after stress and that this pathway is compromised in an animal model of morbid obesity, resulting in the impaired ability to regulate blood pressure during stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043162     DOI: 10.1161/01.HYP.0000247306.53547.d4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Upregulation of orexin receptor in paraventricular nucleus promotes sympathetic outflow in obese Zucker rats.

Authors:  Jing-Jing Zhou; Fang Yuan; Yi Zhang; De-Pei Li
Journal:  Neuropharmacology       Date:  2015-08-12       Impact factor: 5.250

Review 2.  Recording sympathetic nerve activity chronically in rats: surgery techniques, assessment of nerve activity, and quantification.

Authors:  Sean D Stocker; Martin S Muntzel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

Review 3.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

Review 4.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

Review 5.  Implicating the potential role of orexin in hypertension.

Authors:  Monika Rani; Raghuvansh Kumar; Pawan Krishan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-16       Impact factor: 3.000

Review 6.  Heart of the matter: coronary dysfunction in metabolic syndrome.

Authors:  Zachary C Berwick; Gregory M Dick; Johnathan D Tune
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

7.  Insulin resistance in penile arteries from a rat model of metabolic syndrome.

Authors:  Cristina Contreras; Ana Sánchez; Pilar Martínez; Rafaela Raposo; Belén Climent; Albino García-Sacristán; Sara Benedito; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

8.  Impaired coronary function in Wistar Ottawa Karlsburg W rats-a new model of the metabolic syndrome.

Authors:  Olaf Grisk; Tillmann Frauendorf; Torsten Schlüter; Ingrid Klöting; Beate Kuttler; Alexander Krebs; Jan Lüdemann; Rainer Rettig
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

9.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

Review 10.  Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.